세계의 라이브셀 이미징 시장 규모는 2023년 23억 달러에 달했습니다. 향후 IMARC Group은 시장이 2032년까지 46억 달러에 이를 전망이며 예측 기간 동안 7.7%의 복합 연간 성장률(CAGR)을 나타낼 것으로 예측했습니다. 단백질의 연구 효율성에 따른 수요 증가, 신약 개발을 위한 의료 연구에 있어서의 기술 혁신의 진전, 앉기 쉬운 라이프 스타일의 정착에 의한 다양한 만성 질환의 만연 등이 시장을 견인하는 주요 요인 중 하나 입니다.
라이브셀 이미징은 시간이 지남에 따라 변화하는 성장 배지에서 동적 살아있는 세포를 조사하는 것입니다. 현미경 단계에서 세포를 배양하는 상세한 프로토콜과 기술로 구성되며 실시간으로 세포 과정을 추적하기 위해 일정한 초점면을 유지합니다. 위상차 현미경과 명시야에 의존하여 세포 배양을 조명하고, 플라스티드, 미토콘드리아, 중심체, 소포체, 리보솜 등의 다양한 세포소기관을 조사했습니다. 라이브셀 이미징은 이미징 양식, 배지, 온도, 습도, pH, 삼투압, 광자량에 영향을 받지만 이들은 세포의 건강 유지에 필수적입니다. 라이브셀 이미징은 또한 세포 융합 이벤트의 모니터링, 광탈실 후 형광 회복(FRAP)을 이용한 분자의 이동도의 결정, 일정 기간에 있어서의 응축체의 성장이나 노화 등의 다양한 수식의 측정도 가능 합니다. 엔드포인트 분석은 놓치기 쉬운 과도적 사건을 시각화하고 최적의 시간 포인트를 밝히는 것으로 본질적인 세포 데이터를 기재하고 있습니다. 수정 과정, 세포 발달, 세포 신호전달 과정, 세포 분화를 검사하기 위하여 자주 이용됩니다. 또한 라이브셀 이미징은 세포 배양에 대한 정확한 정보를 제공하기 위해 세계의 생물학자, 약리학자, 독물학자에게 활용되고 있습니다.
현재 단백질과 다양한 분자간 상호작용 연구에서 라이브셀 이미징의 운영 효율성으로 인한 수요 증가는 시장에 긍정적인 영향을 미치는 주요 요인 중 하나입니다. 이 외에도 개인의 다양한 생명을 위협하는 상태를 치료하기 위한 신약과 치료법을 개발하기위한 의료 연구의 기술 혁신의 수가 증가하고 있습니다. 이것은 좌석이없는 라이프 스타일을 채택하여 다양한 만성 질환의 유병률이 증가함에 따라 유리한 시장 전망을 제공합니다. 또한, 의약품 개발 프로세스의 시간 효율과 비용 효율성을 높이고 독성을 줄이기 위해 높은 컨텐츠 스크리닝(HCS)의 사용이 증가하고 있다는 점도 시장 성장을 뒷받침하고 있습니다. 이와는 별도로 의료 인프라를 개선하고 환자에게 효과적인 치료를 제공하기 위한 고급 수술을 개발하기 위해 각국의 행정기관이 실시하는 투자 건수가 증가하고 있는 것도 시장의 성장에 기여합니다. 또한, 세포 생존율을 유지하기 위해 연구소에서의 라이브셀 이미징의 채용이 증가하고 있는 것도 시장의 성장을 뒷받침하고 있습니다. 또한 신흥국 시장의 주요 기업은 카메라 기술, 감도, 픽셀 밀도 등 다양한 기능을 강화한 라이브셀 이미징 기술을 개발하고 있습니다.
The global live cell imaging market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7.7% during 2024-2032. The escalating demand due to its operational efficiency in studying proteins, rising innovations made in medical research to develop novel drugs, and the growing prevalence of various chronic diseases due to the adoption of sedentary lifestyles represent some of the key factors driving the market.
Live cell imaging refers to the examination of dynamic living cells in their growth medium that change over time. It comprises detailed protocols and techniques to culture cells on the microscope stage and maintains a constant focal plane to follow cellular processes in real time. It relies on phase contrast microscopy and brightfield to illuminate the cell culture and examine various cell organelles, such as plastids, mitochondria, centrosomes, endoplasmic reticulum, and ribosomes. It is influenced by imaging modality, media, temperature, humidity, pH, osmolarity, and photon dose, which are essential for maintaining cellular health. Live cell imaging also allows monitoring of cell fusion events, determining the mobility of molecules by using fluorescence recovery after photobleaching (FRAP) and measuring various modifications, such as growth or aging of condensate over a period. It provides essential cellular data through the visualization of transient events that are often missed in endpoint assays and revealing optimal time points. It is often utilized to examine the fertilization process, cellular development, cell signaling process, and cell differentiation. Furthermore, as live cell imaging provides accurate information on cell cultures, it is utilized by biologists, pharmacologists, and toxicologists around the world.
At present, the escalating demand for live cell imaging due to its operational efficiency in studying proteins and a wide variety of molecular interactions represents one of the primary factors influencing the market positively. Besides this, there is a rise in the number of innovations made in medical research to develop novel drugs and therapies to treat various life-threatening conditions in individuals. This, coupled with the growing prevalence of various chronic diseases due to the adoption of sedentary lifestyles, is offering a favorable market outlook. In addition, the increasing utilization of high-content screening (HCS) to make drug development processes time and cost-efficient and reduce toxicity is propelling the growth of the market. Apart from this, the rising number of investments made by governing agencies of various countries to improve healthcare infrastructure and develop advanced surgical procedures to provide effective treatment to patients is contributing to the growth of the market. Additionally, the increasing employment of live cell imaging in research laboratories to maintain cell viability is bolstering the market growth. Furthermore, key market players are developing live cell imaging techniques with various enhanced features in camera technology, sensitivity, and pixel density.
IMARC Group provides an analysis of the key trends in each sub-segment of the global live cell imaging market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and technology.
Equipment
Consumable
Software
The report has provided a detailed breakup and analysis of the live cell imaging market based on the product. This includes equipment, consumable, and software. According to the report, equipment represented the largest segment.
Cell Biology
Developmental Biology
Stem Cell and Drug Discovery
Others
A detailed breakup and analysis of the live cell imaging market based on the application has also been provided in the report. This includes cell biology, developmental biology, stem cell and drug discovery, and others. According to the report, cell biology accounted for the largest market share.
Time-Lapse Microscopy
Fluorescence Recovery after Photobleaching (FRAP)
Fluorescence Resonance Energy Transfer (FRET)
High Content Screening (HCS)
Others
A detailed breakup and analysis of the live cell imaging market based on the technology has also been provided in the report. This includes time lapse microscopy, fluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), high content screening (HCS), and others. According to the report, fluorescence recovery after photobleaching (FRAP) accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for live cell imaging. Some of the factors driving the North America live cell imaging market included rising investments made by governing agencies, increasing occurrence of cancer among the masses, the growing initiatives in drug discovery, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global live cell imaging market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have also been provided. Some of the companies covered include Becton Dickinson and Company (BD), Carl Zeiss AG, Leica Microsystems (Danaher Corporation), Merck KGaA, Nikon Instruments Inc., Olympus Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.